Opioids, opioid receptors, and the immune response

Drug and Alcohol Dependence

Volumn 62, Issue 2, 2001, Pages 111-123

  McCarthy, Lois ^a   Wetzel, Michele ^a   Sliker, Judith K ^a   Eisenstein, Toby K ^a   Rogers, Thomas J ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

HIV review; Immune function; Immunobiology; Molecular biology; Opiate abuse

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; BETA ENDORPHIN; CYTOKINE; CYTOKINE RECEPTOR; DELTA OPIATE RECEPTOR; DELTORPHIN[2 DEXTRO ALANINE]; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; IMMUNOMODULATING AGENT; KAPPA OPIATE RECEPTOR; METENKEPHALIN; METENKEPHALIN[2 DEXTRO ALANINE]; METENKEPHALINAMIDE; MIFEPRISTONE; MORPHINE; MU OPIATE RECEPTOR; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; OPIATE AGONIST; OPIATE ANTAGONIST; UNCLASSIFIED DRUG;

ANTIBODY RESPONSE; CHEMOTAXIS; CYTOKINE PRODUCTION; DRUG EFFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; INFECTION RESISTANCE; INFLAMMATION; LYMPHOCYTE FUNCTION; MOLECULAR BIOLOGY; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

ANTIBODIES, VIRAL; APOPTOSIS; HEMATOPOIESIS; HIV SEROPOSITIVITY; HUMANS; IMMUNE SYSTEM; LEUKOCYTES, MONONUCLEAR; MORPHINE; NARCOTICS; NEUROIMMUNOMODULATION; OPIOID-RELATED DISORDERS; RECEPTORS, OPIOID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0035314027     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(00)00181-2     Document Type: Review

References (133)

1. Inhibition of primary murine macrophage cytokine production in vitro following treatment with the κ-opioid agonist U50,488H
2. Characterization of κ-opioid receptor transcripts expressed by T cells and macrophages
3. Morphine-induced immune alterations in vivo
4. Genomic structure of the mouse δ-opioid receptor gene
5. Leu-enkephalin binding to cultured human T lymphocytes
6. Expression of two variants of the human mu opioid receptor mRNA in SK-N-SH cells and human brain
7. Sequence of κ-opioid receptor cDNA in the R1.1 thymoma cell line
8. Inhibition of interleukin-1 and tumor necrosis factor-α synthesis following treatment of macrophages with the kappa opioid agonist U50,488H
9. Detection of κ-opioid receptor mRNA in immature T cells
10. β-Endorphin modulation of IL-1-induced IL-2 production
11. Effects of morphine tolerance and abstinence on cellular immune function
12. κ-opioid binding sites on a murine lymphoma cell line
13. Opioid peptides modulate production of interferon γγ by human mononuclear cells
14. Immunosupressive effects of chronic morphine treatment in mice
15. j (Beige) mice
16. Differential effects of morphine and naltrexone on the antibody response in various mouse strains
17. Cytokine reversal of morphine-induced suppression of the antibody response
18. The role of endogenous opioids and their receptors in the immune system
19. Opioid receptors on cells of the immune system: Evidence for δ- and κ-classes
20. 1
21. Inhibition by opioids of phagocytosis in peritoneal macrophages
22. Lethality of morphine in mice infected with Toxoplasma gondii
23. Morphine potentiates transforming growth factor-β release from human peripheral blood mononuclear cell cultures
24. Upregulation of HIV-1 expression in cocultures of chronically infected promonocytes and human brain cells by dynorphin
25. κ-opioid receptors in human microglia downregulate human immunodeficiency virus 1 expression
26. Activation of Mu opioid receptors inhibits microglial cell chemotaxis
27. Molecular cloning of a rat kappa opioid receptor reveals sequence similarities to the mu and delta opioid receptors
28. Modulation of simian AIDS by opioids
29. Delta opioid receptor gene expression in lymphocytes
30. Expression of kappa opioid receptors in human and monkey lymphocytes
31. Consequences of opiate dependency in a monkey model of AIDS
32. Opiates as potential cofactors in progression of HIV-1 infections to AIDS
33. Immunosuppression to tetanus toxoid induced by implanted morphine pellets
34. Mouse strain differences in immunosuppression by opioids in vitro
35. Opioid modulation of immune responses: Effects on phagocyte and lymphoid cell populations
36. Cloning of a delta opioid receptor by functional expression
37. Stereospecific opiate binding in living human polymorphonuclear leukocytes
38. Host factors and the pathogenesis of HIV-induced disease
39. Opioid binding site in EL-4 thymoma cell line
40. Morphine-induced alterations in thymocyte subpopulations of B6C3F1 mice
41. Morphine induces apoptosis in murine thymocytes in vivo but not in vitro: Involvement of both opiate and glucocorticoid receptors
42. cDNA cloning and regional distribution of a novel member of the opioid receptor family
43. 2 induces up-regulation of murine macrophage β-endorphin receptors
44. β-endorphin protects mice from neurological disease induced by the murine coronavirus MHV-JHM
45. Opiates transdeactivate chemokine receptors: Delta and mu opiate-receptor mediated heterologous desensitization
46. Both T cells and macrophages are targets of κ-opioid-induced immunosuppression
47. Inhibition of T cell superantigen responses following treatment with the κ-opioid agonist U50,488H
48. Modulation of DPK cell function by the kappa opioid agonist agonist U50,488H
49. Functional role and sequence analysis of a lymphocyte orphan opioid receptor
50. Serious infections other than human immunodeficiency virus among intravenous drug users
51. Specific nonopiate receptors for β-endorphin
52. δ-opioid receptors expressed by Jurkat T cells enhance IL-2 secretion by increasing AP-1 complexes and activity of the NF-AT/AP-1-binding promoter element
53. Morphine alters macrophage and lymphocyte populations in the spleen and peritoneal cavity
54. Morphine induces sepsis in mice
55. A comparative study of immunomodulation produced by in vitro exposure to delta opioid receptor agonist peptides
56. Infections resulting from narcotic addiction
57. Effect of high doses of morphine on Con-A induced lymphokine production in vitro
58. The δ-opioid receptor: Isolation of a cDNA by expression cloning and pharmacological characterization
59. The action of drugs in infection. I. The influence of morphine in experimental septicemia
60. Kappa opioid binding sites on the R1.1 murine lymphoma cell line: Sensitivity to cations and guanine nucleotides
61. The kappa opioid receptor expressed on the mouse R1.1 thymoma cell line is coupled to adenylyl cyclase through a pertussis toxin-sensitive guanine nucleotide-binding regulatory protein
62. Effects of certain abused drugs on hemolysin forming cells
63. Infectious endocarditis in intravenous drug abusers
64. Molecular cloning and expression of a rat kappa opioid receptor
65. Met-enkephalin-containing peptides encoded by proenkephalin A mRNA expressed in activated murine thymocytes inhibit thymocyte proliferation
66. Expression and function of proenkephalin A messenger ribonucleic acid in murine fetal thymocytes
67. Effects of in vivo and in vitro administration of morphine sulfate upon Rhesus macaque polymorphonuclear cell phagocytosis and chemotaxis
68. Cloning and promoter mapping of mouse kappa opioid receptor gene
69. Stereoselective muscarinic acetylcholine and opiate receptors in human phagocytic leukocytes
70. The major medical complications of heroin addiction
71. Morphine induced alterations of immune status: Dose dependency, compartment specificity and antagonism by naltrexone
72. Human granulocytes contain an opiate alkaloid-selective receptor mediating inhibition of cytokine-induced activation and chemotaxis
73. β-Endorphin augments the cytolytic activity and interferon production of natural killer cells
74. Changes in T-lymphocyte subsets in intravenous drug users with HIV-1 infection
75. Promoter region and alternatively spliced exons of the rat mu-opioid receptor gene
76. Opiate receptors on lymphocytes and platelets in man
77. 1 receptor
78. Genomic structure analysis of promoter sequence of a mouse mu opioid receptor gene
79. Cloning and expression of a cDNA for the rat kappa-opioid receptor
80. ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization
81. cDNA cloning and pharmacological characterization of an opioid receptor with high affinities for kappa-subtype-selective ligands
82. Structure and chromosomal mapping of genes for the mouse κ-opioid receptor and an opioid receptor homologue (MOR-C)
83. Characterization of opiate binding sites on membranes of rat lymphocytes
84. Macrophage functions in drugs of abuse-treated mice
85. The influence of morphine on development of HSV-1 and M-MSV virus infection in mice
86. Opioids depress in vitro human monocyte chemotaxis
87. Opioid-mediated suppression of cultured peripheral blood mononuclear cell respiratory burst activity
88. Opioid-mediated suppression of interferon-γ production by cultured periferal blood mononuclear cells
89. Suppression of human peripheral blood mononuclear cell function by methadone and morphine
90. Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures
91. Biochemical and functional characterization of an opioid binding site on cells of the immune system
92. Characterization of the cloned human mu opioid receptor
93. Drug dependence, a possible new risk factor for tuberculosis disease
94. Enterococcal endocarditis in heroin addicts
95. Orphanin FQ: A neuropeptide that activates an opioid like G protein-coupled receptor
96. Molecular biology of opioid receptors
97. Effects of morphine dependence on the pathogenesis of swine herpesvirus infection
98. Morphine treatment in vitro or in vivo decreases phagocytic functions of murine macrophages
99. Survival with the aquired immunodeficiency syndrome: Experience with 5833 cases in New York City
100. Morphine modulates NFκB activation in macrophages
101. Chronic morphine treatment selectively supresses macrophage colony formation in bone marrow
102. Differential effects of opioids on the proliferation of a macrophage cell line, Bac 1.2F5
103. Morphine inhibits transcriptional activation of IL-2 in mouse thymocytes
104. Opiate receptor-mediated chemotaxis of human monocytes
105. β-Endorphin: Surface binding and internalization in thymoma cells
106. Complementary DNA cloning of a μ-opioid receptor from rat peritoneal macrophages
107. Morphine-induced thymic hypoplasia is glucocorticoid-dependent
108. + murine T cells
109. Murine splenocytes express a naloxone-insensitive binding site for β-endorphin
110. Expression of naloxone-resistant β-endorphin binding sites on A20 cells: Effects of concanavalin A and dexamethasone
111. Opioid peptides rapidly stimulate superoxide production by human polymorphonuclear leukocytes and macrophages
112. The effect of enkephalins and prostaglandins on O-2 release by neutrophils
113. Human neutrophil migration is enhanced by beta-endorphin
114. Morphine enhances macrophage apoptosis
115. Morphine induces splenocyte apoptosis and enhanced mRNA expression of cathepsin-B
116. Immune status and survival of opiate- and cocaine-treated mice infected with Friend virus
117. Opiate-like substances in an invertebrate, an opiate receptor on invertebrate and human immunocytes, and a role in immunosuppression
118. Suppression of peritoneal macrophage phagocytosis of Candida albicans by opioids
119. The relationship between pharmacokinetics and pharmacodynamic action as applied to in vivo pA2: Application to the analgesic effect of morphine
120. Immunomodulatory activity of μ- and κ-selective opioid agonists
121. Altered hematopoiesis, behavior, and sexual function in μ opioid receptor-deficient mice
122. Effect of morphine on resistance to infection
123. B-endorphin and met-enkephalin stimulate human peripheral blood mononuclear cell chemotaxis
124. Two opposing modes of action of β-endorphin on lymphocyte function
125. + T cells
126. Effects of morphine on the pathogenesis of murine Friend retrovirus infection
127. cDNA cloning of an orphan opiate receptor gene family member and its splice variant
128. Isolation of a novel cDNA encoding a putative membrane receptor with high homology to the cloned mu, delta, and kappa opioid receptors
129. Structure and expression of a rat kappa opioid receptor gene
130. Cloning and functional comparison of κ and δ opioid receptors from mouse brain
131. Cloning of a human κ opioid receptor from the brain
132. Cloning and expression of an isoform of the rat mu opioid receptor (rMOR1B) which differs in agonist induced desensitization from rMOR1